India Value Fund-backed Manipal Health Enterprises has committed INR400 million ($7.27 million) to Ankur Healthcare, which specializes in infertility treatment.
South Asia | 20 May 2013 |
Quadrant Private Equity has exited its investment in fertility services provider Virtus Health via a A$339 million ($330 million) IPO, while making another partial exit from retirement village chain Summerset.
Australasia | 20 May 2013 |
Inviragen had inauspicious beginnings. The firm came about through a marriage of convenience between two biotech start-ups that couldn't get funding: US-based Inviragen was working on dengue fever vaccine but had no capital for clinical trials; over in...
Healthcare | 15 May 2013 |
Vectura, a UK-based drug company, has teamed up with Hong Kong-based PE investor Zendex Bio Strategy and Tianjin KingYork Group to form a joint venture that will develop respiratory products in China and other Asian markets.
Greater China | 14 May 2013 |
Goldman Sachs’ private equity unit has committed INR1.1 billion ($20 million) to BPL Medical Technologies, a subsidiary of listed Indian consumer products manufacturer BPL. This is Goldman's third investment in the Indian healthcare sector.
South Asia | 14 May 2013 |
Biosensors International, a Singapore-listed medical device company backed by Hony Capital, has acquired Spectrum Dynamics, an Israel-based medical imaging and clinical applications company, for $51.13 million.
Greater China | 13 May 2013 |
Ravindranath GE Medical Associates (RGE), which operates a chain of eight hospitals across India under the Global Hospitals brand, will receive $15 million from Sabre Partners and $25 million from the International Finance Corporation.
South Asia | 10 May 2013 |
PE-backed Singapore biopharmaceutical start-up Inviragen is to be acquired by Japan's Takeda Pharmaceutical for $250 million.
Southeast Asia | 09 May 2013 |
Portola Pharmaceuticals, a US-based drug developer whose largest shareholder is Temasek Holdings, plans to raise $127 million through a NASDAQ IPO. The other backers include MPM Capital, Prospect Venture Partners, Brookside Capital, Sutter Hill Ventures,...
Healthcare | 08 May 2013 |
Summerset, a New Zealand care home operator backed by Quadrant Private Equity, is seeking to list on the Australian Securities Exchange in response to increased interest from local investors.
Australasia | 07 May 2013 |
Mercury Capital has taken a 30% stake in Novotech, Australia's largest independent clinical trials provider, with a view to aiding its Asia-Pacific expansion. The amount invested was not disclosed.
Australasia | 02 May 2013 |
Quadrant Private Equity-owned in-vitro fertilization (IVF) business Virtus Health launched its IPO road show on Monday. It is poised to be the largest equity offering since SCA Property in November last year and the biggest significant private equity-backed...
Exits | 30 Apr 2013 |
Shanghai Fosun Pharmaaceutical, a subsidiary of China’s Fosun International, and the Pramerica-Fosun China Opportunity Fund, will be around $240 million to acquire up to 95.6% of Israel-based Alma Lasers.
Greater China | 29 Apr 2013 |
Indian hospital and diagnostics group Fortis Healthcare is to issue 28.6 million shares to the International Finance Corporation (IFC) for a total of $45 million. Another $55 million will come through a private placement of foreign currency convertible...
South Asia | 26 Apr 2013 |
India’s Manipal Group has raised around $260 million in debt to buy back IDFC PE and Capital International’s stake in Manipal Education and Medical Group International India (MEMG).
South Asia | 26 Apr 2013 |
Updating your subscription status
India's private equity industry is in a state of transition, and only funds that are nimble on their feet and adaptive will ultimately survive. Find out what you need to navigate India's changing landscape at the 14th Annual AVCJ Private Equity & Venture India Forum on 5-6 December. Last year's Forum was attended by more than 250 top executives coming from 15 different countries and territories around the globe. Over 50 LPs joined the event, including dozens of foreign investors looking to increase their allocations to India or to invest in the country for the very first time. The conference featured in-depth analysis about India's private equity industry with sessions that covered topics ranging from confronting the difficult exit and fundraising environment, to understanding regulatory changes, to predicting where the industry will likely be in 2015.
Date: 5-6 December 2013
Venue: Tal Lands End, Mumbai
Join us at the 11th Annual AVCJ Private Equity & Venture Australia and New Zealand Forum on 5-7 March at the Four Seasons Hotel in Sydney to find out how funds of varying size are raising capital, sourcing deals and exits, as well as all you need to know to effectively navigate Australasia's changing alternative asset landscape.
After a decade-long mining boom the economy is experiencing a loss of momentum and the resulting deal flow reduction and lack of value in the market means GPs are chasing many of the same acquisition targets. That said, the exit market is recovering with both IPOs and M&A activity picking up, and an increase in LPs appetite for the asset class, and the recent government change means that the industry is cautiously optimistic for the future and expecting a rise in activity over the next 12 months.
, Four Seasons Hotel, Sydney